| Titan Minerals Limited (TTM) ORDINARY FULLY PAID |
Materials |
$208 |
investor Presentation - Melbourne Mining Club
|
22 Jul 2025 1:30PM |
$0.335 |
$0.725 |
risen by
116.42%
|
|
| NICO Resources Limited (NC1) ORDINARY FULLY PAID |
Materials |
$23 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
22 Jul 2025 1:26PM |
$0.100 |
$0.170 |
risen by
70%
|
|
NC1 - Price-sensitive ASX Announcement
Full Release
Key Points
- NICO Resources Limited released its March 2024 quarterly report.
- Significant progress was made on the NC1 project, including FEED activities and partner engagement.
- Technical, environmental, and commercial assessments of NC1 were a primary focus.
- Cost management and project development expenditures were reported.
- The company maintains a cash reserve and outlined its expected cash needs for the next quarter.
- Compliance with ASX Listing Rules was noted.
- Updates on production and exploration activities were provided.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Greenwing Resources Ltd (GW1) ORDINARY FULLY PAID |
Materials |
$30 |
Change of Director's Interest Notice
|
22 Jul 2025 1:24PM |
$0.029 |
$0.059 |
risen by
103.45%
|
|
| Prodigy Gold NL (PRX) ORDINARY FULLY PAID |
Materials |
$25 |
Replacement Appendix 3Y - Mark Edwards
|
22 Jul 2025 1:24PM |
$0.002 |
$0.074 |
risen by
3,600%
|
|
| Osteopore Limited (OSX) ORDINARY FULLY PAID |
Health Care |
$4 |
Ceasing to be a substantial holder
|
22 Jul 2025 1:19PM |
$0.013 |
$0.006 |
fallen by
53.85%
|
|
| Move Logistics Group Limited (MOV) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Industrials |
$19 |
MOVE Continues Positive Progress - Achieves FY25 Targets
|
22 Jul 2025 1:08PM |
$0.215 |
$0.150 |
fallen by
30.23%
|
|
MOV - Price-sensitive ASX Announcement
Full Release
Key Points
- MOV has achieved or is on track to meet FY25 targets.
- Operational improvements have led to increased profitability.
- Efficiency programs have driven down costs.
- Customer service and safety remain top priorities.
- Recent acquisitions have been successfully integrated.
- Service offerings have been optimized for market needs.
- Digital transformation and strategic partnerships are supporting growth.
- The company is maintaining a focus on sustainability.
- MOV continues to deliver value for shareholders with a strong financial position.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kingsland Minerals Ltd (KNG) ORDINARY FULLY PAID |
Materials |
$6 |
Production Target Retraction
|
22 Jul 2025 12:57PM |
$0.160 |
$0.071 |
fallen by
55.63%
|
|
KNG - Price-sensitive ASX Announcement
Full Release
Key Points
- Kingsland Minerals Ltd (KNG) has retracted its previously released production target for the Leliyn Graphite Project.
- The production target and related economic information were released before the completion of a compliant scoping study.
- Such disclosure was not in accordance with ASX Listing Rules and JORC Code requirements.
- Any references to production targets, project economics, or scoping study outcomes should be disregarded until further notice.
- Kingsland Minerals is taking steps to ensure full compliance with regulatory requirements in future announcements.
- The company remains committed to transparency and accurate communication with shareholders and investors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Perpetual Credit Income Trust (PCI) ORDINARY UNITS FULLY PAID |
Financials |
$797 |
Daily Net Tangible Asset Statement
|
22 Jul 2025 12:51PM |
$1.175 |
$1.090 |
fallen by
7.23%
|
|
| Nova Eye Medical Limited (EYE) ORDINARY FULLY PAID |
Health Care |
$34 |
Notification regarding unquoted securities - EYE
|
22 Jul 2025 12:47PM |
$0.150 |
$0.120 |
fallen by
20%
|
|
| Nova Eye Medical Limited (EYE) ORDINARY FULLY PAID |
Health Care |
$34 |
Application for quotation of securities - EYE
|
22 Jul 2025 12:41PM |
$0.150 |
$0.120 |
fallen by
20%
|
|
| Metalstech Limited (MTC) ORDINARY FULLY PAID |
Materials |
$63 |
Application for quotation of securities - MTC
|
22 Jul 2025 12:29PM |
$0.130 |
$0.235 |
risen by
80.77%
|
|
| Objective Corporation Limited (OCL) ORDINARY FULLY PAID |
Information Technology |
$1,011 |
Notification regarding unquoted securities - OCL
|
22 Jul 2025 12:25PM |
$18.590 |
$10.530 |
fallen by
43.36%
|
|
| Gryphon Capital Income Trust (GCI) ORDINARY UNITS FULLY PAID |
Financials |
$1,310 |
Net Tangible Asset Backing
|
22 Jul 2025 12:24PM |
$2.080 |
$2.060 |
fallen by
0.96%
|
|
| Latrobe Magnesium Limited (LMG) ORDINARY FULLY PAID |
Materials |
$63 |
Application for quotation of securities - LMG
|
22 Jul 2025 12:16PM |
$0.013 |
$0.020 |
risen by
60%
|
|
| Norwest Minerals Limited (NWM) ORDINARY FULLY PAID |
Materials |
$12 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
22 Jul 2025 12:15PM |
$0.015 |
$0.011 |
fallen by
26.67%
|
|
NWM - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers activities and cash flow for the period ending 31 March 2024.
- Significant exploration activities occurred at the Bali Copper Project and Arunta West Project.
- A heritage survey was completed at the Bali Copper Project to facilitate further drilling.
- Norwest received a government co-funding grant for drilling at Arunta West.
- The company advanced its Rare Earth Element (REE) exploration programs.
- Cash flow report outlines expenditure primarily on exploration, evaluation, and administration.
- Share issuance activities were conducted under the Option Exercise Program.
- The report provides a summary of available cash and financial position at the end of the quarter.
- Upcoming priorities include further drilling, exploration, and project development activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| American Rare Earths Limited (ARR) ORDINARY FULLY PAID |
Materials |
$244 |
Investor Presentation
|
22 Jul 2025 12:07PM |
$0.405 |
$0.425 |
risen by
4.94%
|
|
| NRW Holdings Limited (NWH) ORDINARY FULLY PAID |
Industrials |
$3,317 |
Becoming a substantial holder from MUFG
|
22 Jul 2025 11:58AM |
$3.170 |
$7.220 |
risen by
127.76%
|
|
| King River Resources Limited (KRR) ORDINARY FULLY PAID |
Materials |
$38 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
22 Jul 2025 11:49AM |
$0.007 |
$0.026 |
risen by
271.43%
|
|
KRR - Price-sensitive ASX Announcement
Full Release
Key Points
- KRR released its Quarterly Activities Report and Appendix 5B for the quarter ending 30 September 2023.
- Primary focus was on the Speewah High Purity Alumina (HPA) project in Western Australia.
- A Pre-Feasibility Study (PFS) was completed, showing positive project economics and viability.
- Next steps for the project include pilot plant test work and progressing permitting and approvals.
- Environmental and heritage surveys were conducted to facilitate project development.
- Engagement with government agencies and continued local community consultation occurred.
- Cash expenditures were detailed, with a focus on project and corporate costs.
- KRR maintained a strong cash position at the end of the quarter.
- There was no mining production or sales during the reporting period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Coles Group Limited (COL) ORDINARY FULLY PAID |
Consumer Staple |
$28,757 |
Advance Notice - 2025 Full Year Results
|
22 Jul 2025 11:43AM |
$20.440 |
$21.410 |
risen by
4.75%
|
|
| Eildon Capital Group (EDC) ORDINARY FULLY PAID |
Financials |
- |
Application for quotation of securities - EDC
|
22 Jul 2025 11:38AM |
$0.850 |
$0.850 |
fallen by
0%
|
|
| I Synergy Group Limited (IS3) ORDINARY FULLY PAID |
Information Technology |
$12 |
Trading Halt
|
22 Jul 2025 11:38AM |
$0.012 |
$0.007 |
fallen by
41.67%
|
|
IS3 - Price-sensitive ASX Announcement
Full Release
Key Points
- IS3 (I Synergy Group Limited) requested a trading halt on 11 June 2024.
- The trading halt is pending an announcement regarding a material transaction.
- The halt will remain until either 13 June 2024 or the material transaction announcement is released.
- IS3 assured its commitment to market transparency.
- The company is not aware of any reason why the trading halt should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| InhaleRx Limited (IRX) ORDINARY FULLY PAID |
Health Care |
- |
Jun25 Appendix 4C Cash Flow Report
|
22 Jul 2025 11:37AM |
$0.041 |
$0.028 |
fallen by
31.71%
|
|
IRX - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly cash flow report for InhaleRx Limited for the quarter ending 30 June 2024
- Net cash used in operating activities with breakdowns for research and development, staff, and administrative costs
- Minor receipt of government grants during the quarter
- Investment expenditure primarily related to property, plant, and equipment
- Financing activities impacted by share issue proceeds and borrowing repayments
- Closing cash and cash equivalents reported for the quarter
- Anticipated cash outflows for the next quarter detailed
- Director's statements on compliance and accuracy of financial reporting included
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| InhaleRx Limited (IRX) ORDINARY FULLY PAID |
Health Care |
- |
Jun25 Quarterly Activities Report
|
22 Jul 2025 11:36AM |
$0.041 |
$0.028 |
fallen by
31.71%
|
|
IRX - Price-sensitive ASX Announcement
Full Release
Key Points
- Advanced clinical trials for inhaled cannabinoid therapeutics.
- Progress made on regulatory submissions for IRX products.
- Continued focus on intellectual property protection.
- Engagement in partnership and collaboration activities.
- Financial updates and cash position commentary provided.
- Positive outlook for future quarters with projected milestones.
- Corporate governance and risk disclosures included.
- Strategic steps taken to secure and commercialize product pipeline.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Medallion Metals Limited (MM8) ORDINARY FULLY PAID |
Materials |
$342 |
Ceasing to be a substantial holder
|
22 Jul 2025 11:32AM |
$0.265 |
$0.430 |
risen by
62.26%
|
|
| Medallion Metals Limited (MM8) ORDINARY FULLY PAID |
Materials |
$342 |
s708A Notice
|
22 Jul 2025 11:29AM |
$0.265 |
$0.430 |
risen by
62.26%
|
|
Call 1300 880 160
Start a chat
Schedule a call
